Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control |
| |
| Affiliation: | 1. INSERM, Unité 657, IFR 99, Université de Bordeaux, Département de Pharmacologie, CHU de Bordeaux, 33076 Bordeaux Cedex, France;2. Novartis Pharma S.A.S., 2-4 rue Lionel Terray, 92506 Rueil Malmaison Cedex, France |
| |
| Abstract: | ![]()
|
| |
| Keywords: | Omalizumab Discontinuation Asthma control Duration of treatment GINA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0035" }," $$" :[{" #name" :" text" ," _" :" global initiative for asthma IgE" },{" #name" :" keyword" ," $" :{" id" :" kwrd0045" }," $$" :[{" #name" :" text" ," _" :" immunoglobulin E FcεRI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0055" }," $$" :[{" #name" :" text" ," _" :" high-affinity IgE receptor BMI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0065" }," $$" :[{" #name" :" text" ," _" :" body mass index forced expiratory volume (1 s) ICS" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" inhaled corticosteroid OCS" },{" #name" :" keyword" ," $" :{" id" :" kwrd0095" }," $$" :[{" #name" :" text" ," _" :" oral corticosteroid |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
